Literature DB >> 32051737

Neuropathic pain releasing calcitonin gene related peptide protects against stroke in rats.

Yida Wang1, Zhenxiu Liu2, Xinyu Ge3, Xinyu Hu4, Xiangyuan Cao1, Lei Li1, Jianhua Xia5, Fulong Li4, Liang Gao1.   

Abstract

Neuropathic pain (NPP) is deemed as a potential risk of stroke; however, recent pieces of evidence showed that calcitonin gene-related peptide is involving in pain progression as well as organ protection. The mechanisms underlying the neuroprotection of calcitonin gene-related peptide are yet poorly described with respect to stroke. The present study showed that the elevated level of calcitonin gene-related peptide-induced by NPP exerts a protective effect against stroke in rats, which was further confirmed in vivo and vitro via mitigation of inflammatory response, inhibition of neuronal cell apoptosis, and increase in regional cerebral blood flow. Repetitive transcranial magnetic stimulation at trigeminal ganglion was performed to simulate to facilitate the release of calcitonin gene-related peptide for a similar neuroprotective effect. Together, these findings posit that the release of calcitonin gene-related peptide-induced by NPP or repetitive transcranial magnetic stimulation protects against stroke in rats. Thus, repetitive transcranial magnetic stimulation could have high application prospects for the prevention and treatment of stroke. AJTR
Copyright © 2020.

Entities:  

Keywords:  Neuropathic pain; calcitonin gene related peptide; repetitive transcranial magnetic stimulation; stroke

Year:  2020        PMID: 32051737      PMCID: PMC7013228     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  39 in total

1.  Mitochondrial metabolomics unravel the primordial trigger of ischemia/reperfusion injury.

Authors:  Michal Heger; Megan J Reiniers; Rowan F van Golen
Journal:  Gastroenterology       Date:  2015-03-28       Impact factor: 22.682

Review 2.  Global brain inflammation in stroke.

Authors:  Kaibin Shi; De-Cai Tian; Zhi-Guo Li; Andrew F Ducruet; Michael T Lawton; Fu-Dong Shi
Journal:  Lancet Neurol       Date:  2019-07-08       Impact factor: 44.182

3.  TRPA1 mediates trigeminal neuropathic pain in mice downstream of monocytes/macrophages and oxidative stress.

Authors:  Gabriela Trevisan; Silvia Benemei; Serena Materazzi; Francesco De Logu; Gaetano De Siena; Camilla Fusi; Mateus Fortes Rossato; Elisabetta Coppi; Ilaria Maddalena Marone; Juliano Ferreira; Pierangelo Geppetti; Romina Nassini
Journal:  Brain       Date:  2016-03-16       Impact factor: 13.501

Review 4.  Apoptosis regulation in the penumbra after ischemic stroke: expression of pro- and antiapoptotic proteins.

Authors:  Anatoly B Uzdensky
Journal:  Apoptosis       Date:  2019-10       Impact factor: 4.677

5.  Impaired vascular remodeling after endothelial progenitor cell transplantation in MMP9-deficient mice suffering cortical cerebral ischemia.

Authors:  Anna Morancho; Feifei Ma; Verónica Barceló; Dolors Giralt; Joan Montaner; Anna Rosell
Journal:  J Cereb Blood Flow Metab       Date:  2015-07-29       Impact factor: 6.200

6.  TRPV1, CGRP and SP in scalp arteries of patients suffering from chronic migraine.

Authors:  Marina Del Fiacco; Marina Quartu; Marianna Boi; M Pina Serra; Tiziana Melis; Riccardo Boccaletti; Elliot Shevel; Carlo Cianchetti
Journal:  J Neurol Neurosurg Psychiatry       Date:  2014-10-06       Impact factor: 10.154

7.  Reduced brain UCP2 expression mediated by microRNA-503 contributes to increased stroke susceptibility in the high-salt fed stroke-prone spontaneously hypertensive rat.

Authors:  Speranza Rubattu; Rosita Stanzione; Franca Bianchi; Maria Cotugno; Maurizio Forte; Floriana Della Ragione; Salvatore Fioriniello; Maurizio D'Esposito; Simona Marchitti; Michele Madonna; Simona Baima; Giorgio Morelli; Sebastiano Sciarretta; Luigi Sironi; Paolo Gelosa; Massimo Volpe
Journal:  Cell Death Dis       Date:  2017-06-22       Impact factor: 8.469

Review 8.  CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?

Authors:  Valentina Favoni; Luca Giani; Linda Al-Hassany; Gian Maria Asioli; Calogera Butera; Irene de Boer; Martina Guglielmetti; Chrysoula Koniari; Theodoros Mavridis; Marge Vaikjärv; Iris Verhagen; Angela Verzina; Bart Zick; Paolo Martelletti; Simona Sacco
Journal:  J Headache Pain       Date:  2019-03-12       Impact factor: 7.277

Review 9.  Mechanisms of Transcranial Magnetic Stimulation Treating on Post-stroke Depression.

Authors:  Xiaoqin Duan; Gang Yao; Zhongliang Liu; Ranji Cui; Wei Yang
Journal:  Front Hum Neurosci       Date:  2018-05-30       Impact factor: 3.169

Review 10.  Noninvasive Brain Stimulation to Enhance Functional Recovery After Stroke: Studies in Animal Models.

Authors:  Julia Boonzaier; Geralda A F van Tilborg; Sebastiaan F W Neggers; Rick M Dijkhuizen
Journal:  Neurorehabil Neural Repair       Date:  2018-10-24       Impact factor: 3.919

View more
  2 in total

Review 1.  Repetitive Transcranial Magnetic Stimulation of the Brain After Ischemic Stroke: Mechanisms from Animal Models.

Authors:  Ying Xing; Yuqian Zhang; Congqin Li; Lu Luo; Yan Hua; Jian Hu; Yulong Bai
Journal:  Cell Mol Neurobiol       Date:  2022-08-02       Impact factor: 4.231

2.  Could CGRP Antagonists Be Helpful in the Fight Against COVID-19?

Authors:  Carrie E Robertson
Journal:  Headache       Date:  2020-06-15       Impact factor: 5.311

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.